With a market cap of $18.3 billion, Secaucus, New Jersey-based Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and services globally. It offers a wide range of ...
BofA raised the firm’s price target on Quest Diagnostics (DGX) to $182 from $179 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results